Documentation Centre

 

 

  of 791 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Insulin resistance causes inflammation in adipose tissue. J Clin Invest. 2018;128:1538-1550 July 19, 2018 Insulin resistance causes inflammation in adipose tissue. J Clin Invest. 2018;128:1538-1550 Shimobayashi M, Albert V, Woelnerhanssen B, Frei IC, Weissenberger D, Meyer-Gerspach AC, Clement N, Moes S, Colombi M, Meier JA, Swierczynska MM, Jenö P, Beglinger C, Peterli R, Hall MN Key Publications
Incidence of components of metabolic syndrome in the metabolically healthy obese over 9 years follow-up: the Atherosclerosis Risk In Communities study. Int J Obes (Lond). 2018;42:295-301 July 17, 2018 Incidence of components of metabolic syndrome in the metabolically healthy obese over 9 years follow-up: the Atherosclerosis Risk In Communities study. Int J Obes (Lond). 2018;42:295-301 Bradshaw PT, Reynolds KR, Wagenknecht LE, Ndumele CE, Stevens J Key Publications
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med. 2018;283:356-370 July 12, 2018 Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med. 2018;283:356-370 Dongiovanni P, Stender S, Pietrelli A, Mancina RM, Cespiati A, Petta S, Pelusi S, Pingitore P, Badiali S, Maggioni M, Mannisto V, Grimaudo S, Pipitone RM, Pihlajamaki J, Craxi A, Taube M, Carlsson LMS, Fargion S, Romeo S, Kozlitina J, Valenti L Key Publications
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med. 2018;283:356-370 July 09, 2018 Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med. 2018;283:356-370 Dongiovanni P, Stender S, Pietrelli A, Mancina RM, Cespiati A, Petta S, Pelusi S, Pingitore P, Badiali S, Maggioni M, Mannisto V, Grimaudo S, Pipitone RM, Pihlajamaki J, Craxi A, Taube M, Carlsson LMS, Fargion S, Romeo S, Kozlitina J, Valenti L Key Publications
Circulating triacylglycerols but not pancreatic fat associate with insulin secretion in healthy humans. Metabolism. 2018;81:113-125 July 04, 2018 Circulating triacylglycerols but not pancreatic fat associate with insulin secretion in healthy humans. Metabolism. 2018;81:113-125 Nowotny B, Kahl S, Klüppelholz B, Hoffmann B, Giani G, Livingstone R, Nowotny PJ, Stamm V, Herder C, Tura A, Pacini G, Hwang JH, Roden M Key Publications
Impact of systemic inflammation on the relationship between insulin resistance and all-cause and cancer-related mortality. Metabolism. 2018;81:52-62 July 03, 2018 Impact of systemic inflammation on the relationship between insulin resistance and all-cause and cancer-related mortality. Metabolism. 2018;81:52-62 Lee DY, Rhee EJ, Chang Y, Sohn CI, Shin HC, Ryu S, Lee WY Key Publications
Risk of Cardiovascular disease and death in individuals with prediabetes defined by different criteria: The Whitehall II study. Diabetes Care. 2018;41:899-906 July 02, 2018 Risk of Cardiovascular disease and death in individuals with prediabetes defined by different criteria: The Whitehall II study. Diabetes Care. 2018;41:899-906 Vistisen D, Witte DR, Brunner EJ, Kivimäki M, Tabák A, Jørgensen ME, Færch K Key Publications
HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing. Diabetologia. 2018;61:839-848 June 22, 2018 HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing. Diabetologia. 2018;61:839-848 Zheng F, Yan L, Yang Z, Zhong B, Xie W Key Publications
Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort. Diabetologia. 2018;61:821-830 June 22, 2018 Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort. Diabetologia. 2018;61:821-830 Johnston LW, Harris SB, Retnakaran R, Giacca A, Liu Z, Bazinet RP, Hanley AJ Key Publications
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2018;61:780-789 June 21, 2018 Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2018;61:780-789 van Steen SC, Woodward M, Chalmers J, Li Q, Marre M, Cooper ME, Hamet P, Mancia G, Colagiuri S, Williams B, Grobbee DE, DeVries JH; ADVANCE Collaborative Group Key Publications

  of 791 Next page

Go to page: of